Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholder's Equity

v3.22.1
Consolidated Statements of Stockholder's Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2020   74,536,000      
Balance at beginning of period at Dec. 31, 2020 $ 391,117 $ 7 $ 602,064 $ 1,435 $ (212,389)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   917,000      
Common stock issued pursuant to equity awards, net 16,566 $ 1 16,565    
Repurchase of common stock (in shares)   (75,000)      
Repurchase of common stock (2,673)   (2,673)    
Stock-based compensation 12,955   12,955    
Other comprehensive income (loss) (989)     (989)  
Net income 3,802       3,802
Balance at end of period (in shares) at Mar. 31, 2021   75,378,000      
Balance at end of period at Mar. 31, 2021 420,778 $ 8 628,911 446 (208,587)
Balance at beginning of period (in shares) at Dec. 31, 2021   76,778,000      
Balance at beginning of period at Dec. 31, 2021 489,198 $ 8 657,485 2,125 (170,420)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   1,037,000      
Common stock issued pursuant to equity awards, net $ 13,835   13,835    
Repurchase of common stock (in shares) (440,449) (440,000)      
Repurchase of common stock $ (26,297)   (26,297)    
Stock-based compensation 18,599   18,599    
Other comprehensive income (loss) (1,075)     (1,075)  
Net income 33,586       33,586
Balance at end of period (in shares) at Mar. 31, 2022   77,375,000      
Balance at end of period at Mar. 31, 2022 $ 527,846 $ 8 $ 663,622 $ 1,050 $ (136,834)